(CBU7) iShares VII Public - Ratings and Ratios
Fixed Income Securities, U.S. Government, Bonds
Description: CBU7 iShares VII Public
The iShares $ Treasury Bond 3-7yr UCITS ETF (CBU7) is designed to track the ICE U.S. Treasury 3-7 Year Bond Index, providing investors with exposure to a specific segment of the U.S. government bond market. By replicating the benchmark index, the fund aims to deliver returns that are in line with the performance of the underlying bonds, minus fees and expenses.
To achieve its investment objective, the fund invests in a diversified portfolio of fixed income securities that comprise the ICE U.S. Treasury 3-7 Year Bond Index. This approach enables the fund to provide investors with a cost-effective and efficient way to gain exposure to the U.S. Treasury bond market, with a focus on the 3-7 year maturity segment.
From a technical analysis perspective, the funds price has been trending downward, with its 20-day, 50-day, and 200-day simple moving averages (SMA) indicating a bearish signal. The current price is 120.66, with an average true range (ATR) of 0.72, representing a volatility of 0.59%. Given the current technical setup, it is likely that the funds price will continue to face resistance at the 121.52 (SMA20) and 122.52 (SMA50) levels.
Fundamentally, the fund has a significant asset base, with approximately 5.77 billion EUR in assets under management (AUM). This scale can provide investors with a high degree of liquidity and potentially lower trading costs. Considering the current interest rate environment and the shape of the yield curve, it is likely that the demand for high-quality government bonds, such as U.S. Treasuries, will remain strong. As a result, the fund is likely to continue to attract investor inflows, supporting its AUM and potentially stabilizing its price.
Forecasting the funds future performance, we can expect the price to be influenced by a combination of technical and fundamental factors. Based on the current technical setup, we can anticipate a potential bounce off the 52-week low of 119.94, with a target price of 122.00 in the short term. However, if the bearish trend persists, the price may continue to decline towards the 119.00 level. From a fundamental perspective, the ongoing demand for U.S. Treasuries and the funds scale are likely to provide a floor for the price. As a result, our forecast suggests that the funds price will stabilize in the range of 119.00-123.00 over the next few months.
Additional Sources for CBU7 ETF
CBU7 ETF Overview
Market Cap in USD | 6,793m |
Category | USD Government Bond |
TER | 0.07% |
IPO / Inception | 2009-06-03 |
CBU7 ETF Ratings
Growth Rating | -0.38 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 0.93 |
Analysts | - |
Fair Price Momentum | 102.85 EUR |
Fair Price DCF | - |
CBU7 Dividends
Currently no dividends paidCBU7 Growth Ratios
Growth Correlation 3m | -74.5% |
Growth Correlation 12m | -16.5% |
Growth Correlation 5y | 35.9% |
CAGR 5y | -1.10% |
CAGR/Max DD 5y | -0.09 |
Sharpe Ratio 12m | 0.22 |
Alpha | -5.59 |
Beta | -0.103 |
Volatility | 6.04% |
Current Volume | 0.5k |
Average Volume 20d | 0.8k |
Stop Loss | 114.4 (-3.5%) |
As of July 09, 2025, the stock is trading at EUR 118.60 with a total of 531 shares traded.
Over the past week, the price has changed by +0.07%, over one month by -1.64%, over three months by -6.19% and over the past year by -2.39%.
Neither. Based on ValueRay´s Analyses, iShares VII Public is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -0.38 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CBU7 is around 102.85 EUR . This means that CBU7 is currently overvalued and has a potential downside of -13.28%.
iShares VII Public has no consensus analysts rating.
According to our own proprietary Forecast Model, CBU7 iShares VII Public will be worth about 111.1 in July 2026. The stock is currently trading at 118.60. This means that the stock has a potential downside of -6.35%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 111.1 | -6.3% |